Skip to main content

Animations

We are charting the path to a future free from Parkinson’s. Your support will get us there.

Olivier Finance, PhD, PharmD

Chief Scientific Officer at Bioprojet Biotech
Location: Saint-Grégoire France

Olivier Finance is a senior drug discovery scientist and executive with over 30 years of experience in pharmaceutical R&D, currently serving as Chief Scientific Officer at Bioprojet. Trained in pharmacology with a PharmD and postdoctoral work in cardiovascular diseases, he has held several leadership roles at Sanofi, covering exploratory research, external innovation, and strategic R&D projects. His work spans multiple therapeutic areas, including cardiovascular, metabolic, inflammatory, and CNS disorders. He has contributed to the discovery and development of numerous drug candidates, with more than twenty reaching clinical stages and two ultimately approved. His experience combines scientific leadership with portfolio strategy and external partnerships. At Bioprojet, he oversees both research and development programs.


Associated Grants

  • Targeting the WDR Domain of LRRK2 for Parkinson’s Disease Therapy

    2026


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.